Indication
Hemolytic Uremic Syndrome
3 clinical trials
3 products
Clinical trial
Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring: Prospective Health-economic Evaluation in Patients in Remission With Atypical Hemolytic Uraemic Syndrome Requiring Long-term Treatment.Status: Active (not recruiting), Estimated PCD: 2023-12-28
Product
EculizumabProduct
Extra blood draw samplesClinical trial
A Phase III Study to Evaluate the Efficacy of INM004 (Shiga Antitoxin) in Pediatric Patients With Shiga Toxin-producing Escherichia Coli-associated Hemolytic Uremic Syndrome.Status: Not yet recruiting, Estimated PCD: 2025-07-28
Product
INM004